These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Thrombosis associated with procainamide-induced lupus anticoagulant. List AF; Doll DC Acta Haematol; 1989; 82(1):50-2. PubMed ID: 2505475 [TBL] [Abstract][Full Text] [Related]
44. Platelet function in patients on maintenance hemodialysis: depressed or enhanced? Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167 [TBL] [Abstract][Full Text] [Related]
45. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus. Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261 [TBL] [Abstract][Full Text] [Related]
46. [Lupus anticoagulant and venous thromboses]. Gil González I; Tortosa Cavero JL; Díaz González G Sangre (Barc); 1988 Aug; 33(4):320-1. PubMed ID: 3142063 [No Abstract] [Full Text] [Related]
48. A true hypercoagulability state in patients on chronic hemodialysis. Erickson RV; Williman M; Pendras JP Trans Am Soc Artif Intern Organs; 1966; 12():205-6. PubMed ID: 5960704 [No Abstract] [Full Text] [Related]
49. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis. Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277 [TBL] [Abstract][Full Text] [Related]
50. [Incidence of chronic renal failure during 35 years at the Rijeka Clinical Hospital Center]. Orlić L; Matić-Glazar D; Vlahović A; Zivcić-Cosić S; Maleta I; Martinović BS; Racki S; Madzar Z Acta Med Croatica; 2004; 58(1):73-7. PubMed ID: 15125398 [TBL] [Abstract][Full Text] [Related]
56. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Freyssinet JM; Cazenave JP Thromb Haemost; 1987 Aug; 58(2):679-81. PubMed ID: 3118497 [No Abstract] [Full Text] [Related]
57. Prevalence of lupus anticoagulant in multiparous women in Benin City, Nigeria. Awodu OA; Ejele OA; Shokunbi WA; Enosolease ME Niger Postgrad Med J; 2003 Mar; 10(1):19-22. PubMed ID: 12812147 [TBL] [Abstract][Full Text] [Related]
58. Hepatic infarction in a patient with the lupus anticoagulant. Mor F; Beigel Y; Inbal A; Goren M; Wysenbeek AJ Arthritis Rheum; 1989 Apr; 32(4):491-5. PubMed ID: 2495803 [TBL] [Abstract][Full Text] [Related]
59. Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. Pötzsch B; Kawamura H; Preissner KT; Schmidt M; Seelig C; Müller-Berghaus G J Lab Clin Med; 1995 Jan; 125(1):56-65. PubMed ID: 7822946 [TBL] [Abstract][Full Text] [Related]
60. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]